Clinical and economic benefits of pharmacist interventions in a non–multiple sclerosis neurology clinic
IHSSP neurology pharmacists in the non-MS setting frequently perform interventions that result in therapy changes and direct cost avoidance. IHSSP pharmacist interventions benefit patients, providers, the healthcare system, and insurers.
Authors
- Sabrina Livezey (ORCID: https://orcid.org/0000-0001-8565-0114)
- Leena Choi (ORCID: https://orcid.org/0000-0002-2544-7090)
- Kayla Johnson (ORCID: https://orcid.org/0000-0002-2247-7307)
- Rosemary Moore
- Morteza Kaveh
- Katie Cruchelow
- Autumn D Zuckerman
Institutions
- Knoxville College (US)
- Vanderbilt Health (US)
- University of Tennessee at Knoxville (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-03-20
- DOI
- https://doi.org/10.1093/ajhp/zxag088
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00